Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 15 of 15 for “"Marketing authorization"”.

  1. From scientific research to healthcare markets

    … in the innovation incentives caused by a drug’s marketing authorization. The third chapter explores the relationship between downstream shifts in demand and upstream research. It studies whether a policy-induced increase in market size affects scientific publishing by universities and …

    lmu-germany Repository record for From scientific research to healthcare markets (opens in a new tab)

  2. Προοπτικές διαμόρφωσης ενιαίου παγκόσμιου νομοθετικού πλαισίου για την κυκλοφορία των φαρμακευτικών προϊόντων φυτικής προέλευσης

    … the objective of harmonizing the conditions for marketing authorization for herbal medicinal products and facilitating free circulation trade. According to this Directive the European Union member states set up a specified simplified registration procedure for Traditional Herbal Medicines …

    greece Repository record for Προοπτικές διαμόρφωσης ενιαίου παγκόσμιου νομοθετικού πλαισίου για την κυκλοφορία των φαρμακευτικών προϊόντων φυτικής προέλευσης (opens in a new tab)

  3. Δίκτυα θεραπειών για χρόνια νοσήματα και επίδραση της φαρμακογενωμικής: κλινική και μεθοδολογική προσέγγιση

    … and safety profile of the treatments with marketing authorization for multiple sclerosis were examined using network meta-analysis. No treatment was found superior in all outcome measures of interest. Finally, a possible relationship between the genetic polymorphism FcgRIIIA-158 V/F in …

    greece Repository record for Δίκτυα θεραπειών για χρόνια νοσήματα και επίδραση της φαρμακογενωμικής: κλινική και μεθοδολογική προσέγγιση (opens in a new tab)

  4. Electronic cigarettes : market entry in Iceland?

    … to youth or non-smokers. An e-cigarette marketing experiment was conducted based on e-cigarettes attributes (relative advantage vs. compatibility) of innovation. A sample of 592 smokers and 224 former smokers participated. Smokers viewed an online advertisement promoting e-cigarettes in …

    reykjavik Repository record for Electronic cigarettes : market entry in Iceland? (opens in a new tab)

  5. From Discovery to Validation: Novel Human Antibodies for Prostate Cancer Treatment

    … being the only one which has received marketing authorization. PSMA is expressed in most prostate cancer lesions but is also found in certain normal tissues, such as salivary glands and kidneys. Prostatic Acid Phosphatase (ACP3) has emerged as a promising alternative target, given its …

    zurich Restricted access

  6. Regulation of biopharmaceuticals, tissue engineering and biogenerics: Key issues for the developer

    … which may influence the outcome of receiving marketing authorization. Most of the results are based on interviews conducted with experts with different backgrounds: regulators, representatives of biocompanies, investors, researchers and representatives of trade associations. Product …

    aalto Repository record for Regulation of biopharmaceuticals, tissue engineering and biogenerics: Key issues for the developer (opens in a new tab)

  7. Format engineering and in vivo validation of novel antibody-fusion proteins for cancer therapy

    … (e.g., IL2, TNFα and, INFα) have gained marketing authorization. However, when administered systemically, they are characterized by small dosage tolerability and severe side effects (e.g., pulmonary, gastrointestinal, hepatic, cardiovascular, hematological, and neurological problems). The …

    trento Repository record for Format engineering and in vivo validation of novel antibody-fusion proteins for cancer therapy (opens in a new tab)

  8. Combinatorial strategy to generate antibody-cytokine fusions with "activity-on-demand" for cancer therapy

    … of certain cytokine payloads have gained marketing authorization for cancer therapy. However, due to their potency and toxicity, recombinant cytokines are typically administered at sub-optimal doses, preventing the use of potentially curative regimens. The antibody-based delivery of …

    trento Repository record for Combinatorial strategy to generate antibody-cytokine fusions with "activity-on-demand" for cancer therapy (opens in a new tab) Embargoed

  9. Regulation, consumption and expenditures of new cancer drugs in Ecuador and Latin America

    … of controversial new cancer drugs by EMA over marketing authorization decisions taken by some LA countries. We showed that 23 (of 28) new cancer drugs approved by LA regulators show no or very modest gain (less than three months) on overall survival. Likewise, LA countries approved most of the …

    ghent Repository record for Regulation, consumption and expenditures of new cancer drugs in Ecuador and Latin America (opens in a new tab)

  10. Isolation and validation of novel monoclonal antibodies targeting the tumor microenvironment for the selective delivery of cytokines payloads

    … system and some cytokine-products have gained marketing authorization for the treatment of cancer. In order to increase the therapeutic index of cytokine payloads, the generation of fusion proteins with tumor-homing antibodies has been proposed. These so-called “immunocytokine” products …

    trento Repository record for Isolation and validation of novel monoclonal antibodies targeting the tumor microenvironment for the selective delivery of cytokines payloads (opens in a new tab)

  11. Generation and Characterization of Antibody-Cytokine Fusion Proteins Targeting the Tumor Neovasculature

    … been among the first immunotherapies that gained marketing authorization for the treatment of advanced cancers. The systemic administration of pro-inflammatory cytokines typically triggers severe side effects (e.g., hypotension, flu-like symptoms nausea, and vomiting), which are associated with an …

    zurich

  12. ANTI-CD25 MONOCLONAL ANTIBODY (MAB):AN IMMUNOMODULATING DRUG CANDIDATE FOR THE TREATMENT OF T-CELL MEDIATED DISEASES

    … programs, to support clinical development and marketing authorization, was followed. The purpose of the thesis was to assess the potential adverse effects resulting from the repeated administration of Anti-CD25 mAb in Cynomolgus monkeys. Selection of the relevant animal species for preclinical …

    milano Repository record for ANTI-CD25 MONOCLONAL ANTIBODY (MAB):AN IMMUNOMODULATING DRUG CANDIDATE FOR THE TREATMENT OF T-CELL MEDIATED DISEASES (opens in a new tab)

  13. VALUTAZIONE DELL'EFFICACIA E DELL'IMMUNOGENICITÀ A LUNGO TERMINE DELLA VACCINAZIONE ANTI-EPATITE B IN ITALIA: ATTUALITÀ E PROSPETTIVE FUTURE.

    … B and Haemophilus influenzae B. In 2005, the marketing authorization of Hexavac vaccine was suspended by the European Medicines Agency (EMA) because of concerns about the long-term immunogenicity of its hepatitis B component. A surveillance programme has been undertaken to verify the long-term …

    milano Repository record for VALUTAZIONE DELL'EFFICACIA E DELL'IMMUNOGENICITÀ A LUNGO TERMINE DELLA VACCINAZIONE ANTI-EPATITE B IN ITALIA: ATTUALITÀ E PROSPETTIVE FUTURE. (opens in a new tab)

  14. AUTOMATION OF SAMPLE PRAPARATION IN BIOANALYTICS FOR HIGH-THROUGHPUT, ACCURATE LC-MS/MS ANALYSIS AND LABORATORY INFORMATION MANAGEMENT SYSTEM

    … or infusion therapies. Merck Serono submitted a marketing authorization application to the European Medicines Agency (EMEA) for Cladribine Tablets in July 2009 and will submit further registration applications for Cladribine Tablets in other countries, including the United States, during Q3 2009. …

    milano Repository record for AUTOMATION OF SAMPLE PRAPARATION IN BIOANALYTICS FOR HIGH-THROUGHPUT, ACCURATE LC-MS/MS ANALYSIS AND LABORATORY INFORMATION MANAGEMENT SYSTEM (opens in a new tab)